Trial Profile
A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase III
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Calcipotriol (Primary)
- Indications Nail disorders; Psoriasis
- Focus Therapeutic Use
- Sponsors Polichem
- 09 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 09 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 28 Mar 2017 Planned initiation date changed from 24 Mar 2017 to 15 May 2017.